Immunogenicity of novel oral poliovirus vaccine type 2 administered concomitantly with bivalent oral poliovirus vaccine: an open-label, non-inferiority, randomised, controlled trial.
Saved in:
| Title: | Immunogenicity of novel oral poliovirus vaccine type 2 administered concomitantly with bivalent oral poliovirus vaccine: an open-label, non-inferiority, randomised, controlled trial. |
|---|---|
| Authors: | Wilkinson AL; US Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: lxq6@cdc.gov., Zaman K; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh., Hoque M; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh., Estivariz CF; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Burns CC; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Konopka-Anstadt JL; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Mainou BA; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Kovacs SD; US Centers for Disease Control and Prevention, Atlanta, GA, USA., An Q; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Lickness JS; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Yunus M; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh., Snider CJ; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Zhang Y; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Coffee E; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Abid T; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Wassilak SGF; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Pallansch MA; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Oberste MS; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Vertefeuille JF; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Anand A; US Centers for Disease Control and Prevention, Atlanta, GA, USA. |
| Source: | The Lancet. Infectious diseases [Lancet Infect Dis] 2023 Sep; Vol. 23 (9), pp. 1062-1071. Date of Electronic Publication: 2023 May 10. |
| Publication Type: | Randomized Controlled Trial; Journal Article; Research Support, U.S. Gov't, P.H.S.; Research Support, Non-U.S. Gov't; Equivalence Trial |
| Journal Info: | Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-4457 (Electronic) Linking ISSN: 14733099 NLM ISO Abbreviation: Lancet Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37178706 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Immunogenicity of novel oral poliovirus vaccine type 2 administered concomitantly with bivalent oral poliovirus vaccine: an open-label, non-inferiority, randomised, controlled trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Wilkinson+AL%22">Wilkinson AL</searchLink>; US Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: lxq6@cdc.gov.<br /><searchLink fieldCode="AU" term="%22Zaman+K%22">Zaman K</searchLink>; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.<br /><searchLink fieldCode="AU" term="%22Hoque+M%22">Hoque M</searchLink>; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.<br /><searchLink fieldCode="AU" term="%22Estivariz+CF%22">Estivariz CF</searchLink>; US Centers for Disease Control and Prevention, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Burns+CC%22">Burns CC</searchLink>; US Centers for Disease Control and Prevention, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Konopka-Anstadt+JL%22">Konopka-Anstadt JL</searchLink>; US Centers for Disease Control and Prevention, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Mainou+BA%22">Mainou BA</searchLink>; US Centers for Disease Control and Prevention, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Kovacs+SD%22">Kovacs SD</searchLink>; US Centers for Disease Control and Prevention, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22An+Q%22">An Q</searchLink>; US Centers for Disease Control and Prevention, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Lickness+JS%22">Lickness JS</searchLink>; US Centers for Disease Control and Prevention, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Yunus+M%22">Yunus M</searchLink>; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.<br /><searchLink fieldCode="AU" term="%22Snider+CJ%22">Snider CJ</searchLink>; US Centers for Disease Control and Prevention, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+Y%22">Zhang Y</searchLink>; US Centers for Disease Control and Prevention, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Coffee+E%22">Coffee E</searchLink>; US Centers for Disease Control and Prevention, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Abid+T%22">Abid T</searchLink>; US Centers for Disease Control and Prevention, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Wassilak+SGF%22">Wassilak SGF</searchLink>; US Centers for Disease Control and Prevention, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Pallansch+MA%22">Pallansch MA</searchLink>; US Centers for Disease Control and Prevention, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Oberste+MS%22">Oberste MS</searchLink>; US Centers for Disease Control and Prevention, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Vertefeuille+JF%22">Vertefeuille JF</searchLink>; US Centers for Disease Control and Prevention, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Anand+A%22">Anand A</searchLink>; US Centers for Disease Control and Prevention, Atlanta, GA, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101130150%22">The Lancet. Infectious diseases</searchLink> [Lancet Infect Dis] 2023 Sep; Vol. 23 (9), pp. 1062-1071. <i>Date of Electronic Publication: </i>2023 May 10. – Name: TypePub Label: Publication Type Group: TypPub Data: Randomized Controlled Trial; Journal Article; Research Support, U.S. Gov't, P.H.S.; Research Support, Non-U.S. Gov't; Equivalence Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science%22">Elsevier Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101130150 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1474-4457 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214733099%22">14733099 </searchLink><i>NLM ISO Abbreviation: </i>Lancet Infect Dis <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37178706 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/S1473-3099(23)00139-1 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1062 Titles: – TitleFull: Immunogenicity of novel oral poliovirus vaccine type 2 administered concomitantly with bivalent oral poliovirus vaccine: an open-label, non-inferiority, randomised, controlled trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Wilkinson AL – PersonEntity: Name: NameFull: Zaman K – PersonEntity: Name: NameFull: Hoque M – PersonEntity: Name: NameFull: Estivariz CF – PersonEntity: Name: NameFull: Burns CC – PersonEntity: Name: NameFull: Konopka-Anstadt JL – PersonEntity: Name: NameFull: Mainou BA – PersonEntity: Name: NameFull: Kovacs SD – PersonEntity: Name: NameFull: An Q – PersonEntity: Name: NameFull: Lickness JS – PersonEntity: Name: NameFull: Yunus M – PersonEntity: Name: NameFull: Snider CJ – PersonEntity: Name: NameFull: Zhang Y – PersonEntity: Name: NameFull: Coffee E – PersonEntity: Name: NameFull: Abid T – PersonEntity: Name: NameFull: Wassilak SGF – PersonEntity: Name: NameFull: Pallansch MA – PersonEntity: Name: NameFull: Oberste MS – PersonEntity: Name: NameFull: Vertefeuille JF – PersonEntity: Name: NameFull: Anand A IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2023 Sep Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1474-4457 Numbering: – Type: volume Value: 23 – Type: issue Value: 9 Titles: – TitleFull: The Lancet. Infectious diseases Type: main |
| ResultId | 1 |